<DOC>
	<DOCNO>NCT00316524</DOCNO>
	<brief_summary>The primary objective study evaluate immune response single vaccination pre-immune subject compare two vaccination naive subject . In addition study investigate safety profile MVA-BN® healthy population compare placebo .</brief_summary>
	<brief_title>A Randomized , Double-blind , Placebo-controlled Study Immunogenicity Safety MVA-BN ( IMVAMUNE™ ) Smallpox Vaccine Healthy Subjects</brief_title>
	<detailed_description>The study consist 4 group , receive either MVA-BN , MVA-BN two time , MVA-BN follow placebo , two administration placebo .</detailed_description>
	<mesh_term>Smallpox</mesh_term>
	<criteria>1 . Male female subject 18 55 year age . 2 . Women must negative serum pregnancy test screen negative urine serum pregnancy test within 24 hour prior vaccination . 3 . Women childbearing potential must use acceptable method contraception 30 day prior first vaccination , must agree use acceptable method contraception study , must become pregnant least 28 day last vaccination . A woman consider childbearing potential unless postmenopausal surgically sterilize . ( Acceptable contraception method restrict abstinence , barrier contraceptive , intrauterine contraceptive device license hormonal product . ) 4 . Lab value without clinically significant finding 5 . Electrocardiogram ( ECG ) without abnormal finding ( e.g . kind atrioventricular intraventricular condition block complete left right bundle branch block , AVnode block , QTc PR prolongation , premature atrial contraction atrial arrhythmia , sustain ventricular arrhythmia , 2 premature ventricular contraction ( PVC ) row , ST elevation consistent ischemia ) . 1 . Uncontrolled serious infection i.e . respond antimicrobial therapy . 2 . History active autoimmune disease . Persons vitiligo thyroid disease take thyroid replacement exclude . 3 . Known suspected impairment immunologic function include , limited , clinically significant liver disease ; diabetes mellitus ; moderate severe kidney impairment . 4 . History malignancy , squamous cell basal cell skin cancer , unless surgical excision consider achieved cure . Subjects history skin cancer vaccination site exclude . 5 . History coronary heart disease , myocardial infarction , angina , congestive heart failure , cardiomyopathy , stroke transient ischemic attack , uncontrolled high blood pressure , heart condition care doctor . 6 . History immediate family member ( father , mother , brother , sister ) die due ischemic heart disease age 50 year . 7 . Ten percent great risk develop myocardial infarction coronary death within next 10 year use National Cholesterol Education Program 's risk assessment tool . ( http : //hin.nhlbi.nih.gov/atpiii/calculator.asp ? usertype=prof ) NOTE : This criterion apply volunteer 20 year age old . 8 . History anaphylaxis severe allergic reaction . 9 . Immune modulatory therapy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Smallpox</keyword>
	<keyword>Vaccination</keyword>
	<keyword>Prevention</keyword>
</DOC>